BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30350394)

  • 1. Diagnostic value of HBME-1, CK19, Galectin 3, and CD56 in the subtypes of follicular variant of papillary thyroid carcinoma.
    Cho H; Kim JY; Oh YL
    Pathol Int; 2018 Nov; 68(11):605-613. PubMed ID: 30350394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
    Murtezaoglu AR; Gucer H
    Pol J Pathol; 2017; 68(1):1-10. PubMed ID: 28547974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary Thyroid Carcinoma.
    Song YS; Won JK; Yoo SK; Jung KC; Kim MJ; Kim SJ; Cho SW; Lee KE; Yi KH; Seo JS; Park YJ
    Thyroid; 2018 Nov; 28(11):1468-1478. PubMed ID: 30226444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of HBME-1 and CD56 in follicular variant of papillary carcinoma in children: An immunohistochemical study and their diagnostic utility.
    Skaria PE; Ahmed AA; Yin H; Nicol K; Reid KJ; Singh V
    Pathol Res Pract; 2019 May; 215(5):880-884. PubMed ID: 30711197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenge in the Pathological Diagnosis of the Follicular- Patterned Thyroid Lesions.
    Elsers DA; Hussein MRA; Osman MH; Mohamed GA; Hosny G
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3365-3376. PubMed ID: 34711014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics of Subtypes of Follicular Variant Papillary Thyroid Carcinoma.
    Kim MJ; Won JK; Jung KC; Kim JH; Cho SW; Park DJ; Park YJ
    Thyroid; 2018 Mar; 28(3):311-318. PubMed ID: 29343212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.
    Paunovic I; Isic T; Havelka M; Tatic S; Cvejic D; Savin S
    APMIS; 2012 May; 120(5):368-79. PubMed ID: 22515291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of tumor markers in the diagnosis of papillary thyroid carcinoma alone and in combination.
    Ma H; Xu S; Yan J; Zhang C; Qin S; Wang X; Li N
    Pol J Pathol; 2014 Oct; 65(3):202-9. PubMed ID: 25372417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma: A Review of 179 Cases.
    Yang GCH; Fried KO; Scognamiglio T
    Diagn Cytopathol; 2017 Jun; 45(6):533-541. PubMed ID: 28332339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry Helps to Distinguish Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features/Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma with Other Follicular Thyroid Lesions.
    Chuang HW; Wang JS; Tsai JW; Hsu CT; Lin KJ
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833464
    [No Abstract]   [Full Text] [Related]  

  • 11. Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features.
    Fu G; Polyakova O; MacMillan C; Ralhan R; Walfish PG
    EBioMedicine; 2017 Apr; 18():50-55. PubMed ID: 28363612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
    Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.
    Park YJ; Kwak SH; Kim DC; Kim H; Choe G; Park DJ; Jang HC; Park SH; Cho BY; Park SY
    J Korean Med Sci; 2007 Aug; 22(4):621-8. PubMed ID: 17728499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.
    Mataraci EA; Ozgüven BY; Kabukçuoglu F
    Pol J Pathol; 2012 Mar; 63(1):58-64. PubMed ID: 22535608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
    Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
    Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 is highly expressed in nonencapsulated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothelial cell 1 immunoreactivity.
    Torregrossa L; Faviana P; Camacci T; Materazzi G; Berti P; Minuto M; Elisei R; Vitti P; Miccoli P; Basolo F
    Hum Pathol; 2007 Oct; 38(10):1482-8. PubMed ID: 17597183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.
    Dunđerović D; Lipkovski JM; Boričic I; Soldatović I; Božic V; Cvejić D; Tatić S
    Diagn Pathol; 2015 Oct; 10():196. PubMed ID: 26503236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Profiles of Noninvasive, Minimally Invasive, and Invasive Follicular Patterned Thyroid Neoplasms with Papillary Nuclear Features.
    Brandler TC; Zhou F; Liu CZ; Serrano A; Sun W; Nikiforov YE; Hodak SP
    Thyroid; 2023 Jun; 33(6):715-723. PubMed ID: 37014083
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic value of HBME-1, CD56, Galectin-3 and Cytokeratin-19 in papillary thyroid carcinomas and thyroid tumors of uncertain malignant potential.
    Nechifor-Boilă A; Cătană R; Loghin A; Radu TG; Borda A
    Rom J Morphol Embryol; 2014; 55(1):49-56. PubMed ID: 24715165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.